CYTK
Cytokinetics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.52B
P/E Ratio
—
EPS
$-6.85
Beta
0.43
52W High
$80.20
52W Low
$31.99
50-Day MA
$70.12
200-Day MA
$63.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
117.65
PEG Ratio
-0.42
About Cytokinetics Inc
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $105.81M |
| Gross Profit (TTM) | $-307.63M |
| EBITDA | $-629.04M |
| Operating Margin | -949.00% |
| Return on Equity | -572.00% |
| Return on Assets | -31.50% |
| Revenue/Share (TTM) | $0.87 |
| Book Value | $-6.65 |
| Price-to-Book | 60.31 |
| Price-to-Sales (TTM) | 90.01 |
| EV/Revenue | 94.47 |
| EV/EBITDA | -15.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1126.00% |
| Shares Outstanding | $135.77M |
| Float | $123.87M |
| % Insiders | 0.70% |
| % Institutions | 118.80% |
Historical Volatility
HV 10-Day
45.15%
HV 20-Day
37.32%
HV 30-Day
59.72%
HV 60-Day
49.84%
HV Rank
77.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($104.70 target)
7
Strong Buy12
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026